1:25 Nilotinib Therapy in Frontline CML August 1, 2022 • CML Content Hub Timothy Hughes, of SAHMRI, discusses #frontline #nilotinib therapy in #CML.
5:06 Prior Bariatric Surgery: Suggestive of Worse Outcomes in CML Patients July 18, 2022 • CML Content Hub @FadiHaddad_MD of @MDAndersonNews, discusses #bariatric surgery in #CML.
Telehealth Use In Neurology July 2, 2022 • Neurology @nbusis, @dammgoodsleep, @nzecavati, and Benjamin Kummer, MD, of @IcahnMountSinai discuss #telehealth in #neurology.
37:28 Update: Clinical Practice Guideline on the Management of Hyperglycemia in Hospitalized Patients July 1, 2022 • Diabetes @MaryKorytkowski, @YMMelodyCheung, and @GeethikaPThota discuss #guidelines for #Type2Diabetes.
2:19 Promising Two-Year Trial Data on Asciminib vs Bosutinib June 25, 2022 • CML Content Hub Timothy Hughes, MD, of @sahmriAU, discusses improved #outcomes with #asciminib.
41:10 Activity in Children: Movement and Physical Literacy June 21, 2022 • Pediatrics Monique Burton, MD, Grace Katt, LAT, ATC; Julia Olson, MEd, LAT, ATC, CSCS; and Carlos Orlina, LAT, ATC, CES, PES, of @seattlechildren, discuss physical literacy and activity in…
1:01 Progress Toward Treatment Discontinuation in CML June 20, 2022 • CML Content Hub @GCC_Cortes of @GACancerCenter discusses treatment #discontinuation among patients with #CML.
5:28 Liquid Biopsy in Lung Cancer Decreases Time to Treatment June 20, 2022 • Oncology Miguel Garcia-Pardo, MD, of @pmcancercentre, discusses #liquidbiopsy in #lungcancer.
22:34 Roundtable on VEGF TKI/Immune Checkpoint Inhibitor Therapy in Renal Cell Cancer June 10, 2022 • Nephrology @motzermd, @DrChoueiri, @AlbigesL, and Robert A Figlin, MD, discuss combined #TKI and #ICI therapy in #RCC.
5:30 Importance of Screening, Early Detection, and Precision Medicine in Myeloma June 10, 2022 • Multiple Myeloma Content Hub @IreneGhobrial, of @DanaFarber, discusses early #screening in #myeloma.
12:20 Phase 3 Trial Data for Next-Generation Enzyme Therapy in Pompe Disease June 10, 2022 • Pompe Disease Content Hub Priya Kishnani, MD, of @DukeOTC, discusses #treatment for #PompeDisease.
46:54 Multidisciplinary Management of Chronic Myeloid Leukemia in the Later-Line Setting May 22, 2022 • CML Content Hub Experts discuss the importance of a #multidisciplinary #team in the #management of #CML.